The Pathological and Clinical Effects of Preoperative Chemoradiation in Rectal Cancer
![]() |
Song, Jin-Ho
(Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine)
Jang, Hong-Seok (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) Kim, Yeon-Sil (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) Chung, Su-Mi (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) Son, Seok-Hyun (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) Kang, Jin-Hyeong (Department of Medical Onocology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) Youk, Eui-Gon (Department of Colorectal Surgery, Daehang Hospital) Lee, Doo-Seok (Department of Colorectal Surgery, Daehang Hospital) Lee, Suk-Hi (Department of Clinical Pathology, Daehang Hospital) Yoon, Sei-Chul (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine) |
1 | Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-987 DOI ScienceOn |
2 | Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B; Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902 DOI ScienceOn |
3 | Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000;284:1008-1015 DOI ScienceOn |
4 | Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-4625 DOI ScienceOn |
5 | Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123 DOI ScienceOn |
6 | Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol 2004;22:2404-2409 DOI ScienceOn |
7 | Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:665-677 DOI ScienceOn |
8 | Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 2005;23:5620-5627 DOI ScienceOn |
9 | National Comprehensive Cancer Network. Clinical practice guidelines in oncology V. 2. 2009: Rectal cancer. Fort Washington, PA: National Comprehensive Cancer Network; c2011 [cited 2011 Jan 30]. Available from: http://www.nccn.org/professionals/physician_gls/PDC/rectal.pdf |
10 | Yoon MS, Nam TK, Kim HR, et al. Results of preoperative concurrent chemoradiotherapy for the treatment of rectal cancer. J Korean Soc Ther Radiol Oncol 2008;26:247-256 DOI |
11 | Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13 DOI ScienceOn |
12 | Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107 DOI ScienceOn |
13 | Rullier A, Laurent C, Capdepont M, et al. Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2010;34:562-568 DOI ScienceOn |
14 | Kim DY, Kim TH, Jung KH, et al. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01). Dis Colon Rectum 2006;49:1684-1691 DOI ScienceOn |
15 | Saif MW, Hashmi S, Zelterman D, Almhanna K, Kim R. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer: a retrospective review. Int J Colorectal Dis 2008;23:139-145 DOI ScienceOn |
16 | De Paoli A, Chiara S, Luppi G, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006;17:246-251 DOI |
17 | Lee J, Kang HC, Chie EK, et al. Effect of suboptimal chemotherapy on preoperative chemoradiation in rectal Cancer. J Korean Soc Ther Radiol Oncol 2009;27:78-83 DOI |
18 | Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007;109:1750-1755 DOI ScienceOn |
19 | National Cancer Information Center. Cancer statistics, 2007. Goyang: National Cancer Information Center; [cited 2011 Jan 30]. Available from: http://www.cancer.go.kr/cms/statics/incidence |
20 | Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96 DOI ScienceOn |
21 | Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740 DOI ScienceOn |
22 | Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-627 DOI ScienceOn |
23 | Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007;69:1167-1172 DOI ScienceOn |
24 | Kim JS, Kim JM, Li S, et al. Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2006;66:195-200 DOI ScienceOn |
25 | Smith FM, Reynolds JV, Kay EW, et al. COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2006;64:466-472 DOI ScienceOn |
26 | Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107 DOI ScienceOn |
27 | O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-507 DOI ScienceOn |
28 | Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883-888 DOI ScienceOn |
29 | Crane CH, Sargent DJ. Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need? J Clin Oncol 2004;22:2978-2981 DOI ScienceOn |
30 | Smalley SR, Benedetti JK, Williamson SK, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006;24:3542-3547 DOI ScienceOn |
31 | Saif MW, Hashmi S, Zelterman D, Almhanna K, Kim R. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer: a retrospective review. Int J Colorectal Dis 2008;23:139-145 DOI ScienceOn |
32 | Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010;28:1638-1644 DOI ScienceOn |
33 | Mehta VK, Cho C, Ford JM, et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003;55:132-137 DOI ScienceOn |
34 | Glynne-Jones R, Sebag-Montefiore D, Maughan TS, Falk SJ, McDonald AC. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-56 DOI |
35 | Lee J, Lee KJ. Clinical factors predicting the pathologic tumor response after preoperative concurrent chemoradio-therapy for rectal cancer. J Korean Soc Ther Radiol Oncol 2008;26:213-221 DOI |
36 | Choi SG, Kim SS, Bae HS. Results of preoperative concurrent chemoradiotherapy for locally advanced rectal cancer. J Korean Soc Ther Radiol Oncol 2007;25:34-42 |
37 | Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-29 DOI |
38 | Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388-396 DOI |
![]() |